申请人:Nickel Bernd
公开号:US20080027110A1
公开(公告)日:2008-01-31
The invention relates to the use of N-substituted indole-3-glyoxylamides of the general formula I as antitumor agents
and to a pharmaceutical composition having antitumor action, characterized in that it contains at least one of the compounds of the general formula 1, if appropriate also in the form of the physiologically tolerable acid addition salts or N-oxides. Furthermore, the invention also includes antitumor agents comprising as active compound one or more N-substituted indole-3-glyoxylamides according to the general formula 1 and, if appropriate, their physiologically tolerable acid addition salts and, if possible, N-oxides and a pharmaceutically utilizable carrier and/or diluent or auxiliary substance in the form of tablets, coated tablets, capsules, solutions for infusion or ampoules, suppositories, patches, powder preparations which can be employed by inhalation, suspensions, creams and ointments.
本发明涉及使用一般式I的N-取代吲哚-3-甘氧酰胺作为抗肿瘤剂,以及具有抗肿瘤作用的药物组合物,其特征在于至少含有一种一般式1的化合物,如适当,还可以是生理耐受的酸加成盐或N-氧化物的形式。此外,本发明还包括作为活性化合物的一种或多种N-取代吲哚-3-甘氧酰胺的抗肿瘤剂,以及它们的生理耐受的酸加成盐和可能的N-氧化物,以及在片剂、包衣片剂、胶囊、输注溶液或安瓿、栓剂、贴片、可通过吸入使用的粉剂制剂、悬浮液、乳霜和软膏等药物可利用载体和/或稀释剂或辅助物质的形式。